Combined microsatellite and FGFR3 mutation analysis enables a highly sensitive detection of urothelial cell carcinoma in voided urine

Clinical Cancer Research

Volumn 9, Issue 1 I, 2003, Pages 257-263

  Van Rhijn, Bas W G ^a,b   Lurkin, Irene ^a   Chopin, Dominique K ^c   Kirkels, Wim J ^b   Thiery, Jean Paul ^d   Van der Kwast, Theo H ^a   Radvanyi, François ^d   Zwarthoff, Ellen C ^a  

^a JOSEPHINE NEFKENS INSTITUTE   (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

^c HENRI MONDOR HOSPITAL   (France)

^d INSTITUT CURIE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

FIBROBLAST GROWTH FACTOR RECEPTOR 3; MICROSATELLITE DNA;

ADULT; AGED; ARTICLE; CLONAL VARIATION; CONTROLLED STUDY; CYTOGENETICS; DNA DETERMINATION; EXON; FEMALE; GENE MUTATION; HUMAN; HUMAN TISSUE; LEUKOCYTURIA; MAJOR CLINICAL STUDY; MALE; MUTATIONAL ANALYSIS; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; URINALYSIS; URINE CYTOLOGY; UROGENITAL TRACT TUMOR; UROTHELIAL CELL CARCINOMA;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA; DNA MUTATIONAL ANALYSIS; FEMALE; HUMANS; LOSS OF HETEROZYGOSITY; MALE; MICROSATELLITE REPEATS; MIDDLE AGED; MUTATION; PROTEIN-TYROSINE KINASES; RECEPTOR, FIBROBLAST GROWTH FACTOR, TYPE 3; RECEPTORS, FIBROBLAST GROWTH FACTOR; UROLOGIC NEOPLASMS; UROTHELIUM;

EID: 0037239824     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Greenlee, R. T., Hill-Harmon, M. B., Murray, T., and Thun, M. Cancer statistics, 2001. CA Cancer J. Clin., 51: 15-36, 2001.
2. Stein, J. P., Grossfeld, G. D., Ginsberg, D. A., Esrig, D., Freeman, J. A., Figueroa, A. J., Skinner, D. G., and Cote, R. J. Prognostic markers in bladder cancer: a contemporary review of the literature. J. Urol., 160: 645-659, 1998.
3. Zieger, K., Wolf, H., Olsen, P. R., and Hojgaard, K. Long-term follow-up of noninvasive bladder tumours (stage Ta): recurrence and progression. B. J. U. Int., 85: 824-828, 2000.
4. Holmäng, S., Hedelin, H., Anderström, C., and Johansson, S. L. The relationship among multiple recurrences, progression and prognosis of patients with stages Ta and Tl transitional cell cancer of the bladder followed for at least 20 years. J. Urol., 153: 1823-1827, 1995.
5. Bastacky, S., Ibrahim, S, Wilczynski, S. P., and Murphy, W. M. The accuracy of urinary cytology in daily practice. Cancer (Phila.), 87: 118 -128, 1999.
6. van der Poel, H. G., and Debruyne, F. M. Can biological markers replace cystoscopy? An update. Curr. Opin. Urol., 11: 503-509, 2001.
7. Lokeshwar, V. B., and Soloway, M. S. Current bladder tumor tests: Does their projected utility fulfill clinical necessity? J. Urol., 165: 1067-1077, 2001.
8. Knowles, M. A., Elder, P. A., Williamson, M., Cairns, J. P., Shaw, M. E., and Law, M. G. Allelotype of human bladder cancer. Cancer Res., 54: 531-538, 1994.
9. Primdahl, H., von der Maase, H., Christensen, M., Wolf, H., and Orntoft, T. F. Allelic deletions of cell growth regulators during progression of bladder cancer. Cancer Res., 60: 6623-6629, 2000.
10. Hafner, C., Knuechel, R., Zanardo, L., Dietmaier, W., Blaszyk, H., Cheville, J., Hofstaedter, F., and Hartmann, A. Evidence for oligoclonality and tumor spread by intraluminal seeding in multifocal urothelial carcinomas of the upper and lower urinary tract. Oncogene, 20: 4910-4915, 2001.
11. Takahashi, T., Habuchi, T., Kakehi, Y., Mitsumori, K., Akao, T., Terachi, T., and Yoshida, O. Clonal and chronological genetic analysis of multifocal cancers of the bladder and upper urinary tract. Cancer Res., 58: 5835-5841, 1998.
12. Louhelainen, J., Wijkstrom, H., and Hemminki, K. Initiation-development modelling of allelic losses on chromosome 9 in multifocal bladder cancer. Eur. J. Cancer, 36: 1441-1451, 2000.
13. Wada, T., Louhelainen, J., Hemminki, K., Adolfsson, J., Wijkstrom, H., Norming, U., Borgstrom, E., Hansson, J., Sandstedt, B., and Steineck, G. Bladder cancer: allelic deletions at and around the retino-blastoma tumor suppressor gene in relation to stage and grade. Clin. Cancer Res., 6: 610-615, 2000.
14. Mao, L., Lee, D. J., Tockman, M. S., Erozan, Y. S., Askin, F., and Sidransky, D. Microsatellite alterations as clonal markers for the detection of human cancer. Proc. Natl. Acad. Sci. USA, 91: 9871-9875, 1994.
15. Mao, L., Schoenberg, M. P., Scicchitano, M., Erozan, Y. S., Merlo, A., Schwab, D., and Sidransky, D. Molecular detection of primary bladder cancer by microsatellite analysis. Science (Wash. DC), 271: 659-662, 1996.
16. Steiner, G., Schoenberg, M. P., Linn, J. F., Mao, L., and Sidransky, D. Detection of bladder cancer recurrence by microsatellite analysis of urine. Nat. Med., 3: 621-624, 1997.
17. Mourah, S., Cussenot, O., Vimont, V., Desgrandchamps, F., Teillac, P., Cochant-Priollet, B., Le Duc, A., Fiet, J., and Soliman, H. Assessment of microsatellite instability in urine in the detection of transitional-cell carcinoma of the bladder. Int. J. Cancer, 79: 629-633, 1998.
18. Schneider, A., Borgnat, S., Lang, H., Regine, O., Lindner, V., Kassem, M., Saussine, C., Oudet, P., Jacqmin, D., and Gaub, M. P. Evaluation of microsatellite analysis in urine sediment for diagnosis of bladder cancer. Cancer Res., 60: 4617-4622, 2000.
19. Zhang, J., Fan, Z., Gao, Y., Xiao, Z., Li, C., An, Q., and Cheng, S. Detecting bladder cancer in the Chinese by microsatellite analysis: ethnic and etiologic considerations. J. Natl. Cancer Inst., 93: 45-50, 2001.
20. van Rhijn, B. W., Lurkin, I., Kirkels, W. J., van der Kwast, T. H., and Zwarthoff, E. C. Microsatellite analysis-DNA test in urine competes with cystoscopy in follow-up of superficial bladder carcinoma: a phase II trial. Cancer (Phila.), 92: 768-775, 2001.
21. Larsson, P. C., Beheshti, B., Sampson, H. A., Jewett, M. A., and Shipman, R. Allelic deletion fingerprinting of urine cell sediments in bladder cancer. Mol. Diagn., 6: 181-188, 2001.
22. Capellen, D., De Oliveira, C., Ricol, D., Gil Diez de Medina, S., Bourdin, J., Sastre-Garau, X., Chopin, D., Thiery, J. P., and Radvanyi, F. Frequent activating mutations of FGFR3 in human bladder and cervix carcinomas. Nat. Genet., 23: 18-20, 1999.
23. Sibley, K., Cuthbert-Heavens, D., and Knowles, M. A. Loss of heterozygosity at 4p16.3 and mutation of FGFR3 in transitional cell carcinoma. Oncogene, 20: 686-691, 2001.
24. van Rhijn, B. W., Lurkin, I., Radvanyi, F., Kirkels, W. J., van der Kwast, T. H., and Zwarthoff, E. C. The fibroblast growth factor receptor 3 (FGFR3) mutation is a strong indicator of superficial bladder cancer with low recurrence rate. Cancer Res., 61: 1265-1268, 2001.
25. Billerey, C., Chopin, D., Aubriot-Lorton, M. H., Ricol, D., Gil Diez de Medina, S., Van Rhijn, B., Bralet, M. P., Lefrere-Belda, M. A., Lahaye, J. B., Abbou, C. C., Bonaventure, J., Zafrani, E. S., van der Kwast, T., Thiery, J-P., and Radvanyi, F. Frequent FGFR3 mutations in papillary non-invasive bladder (pTa) tumors. Am. J. Pathol., 158: 1955-1959, 2001.
26. WHO. Mostofi, F. K., Sobin, L. H., and Torloni, H. Histological typing of urinary bladder turnouts. In: International Classification of Tumours, no. 10, pp. 21-31. Geneva: WHO, 1973.
27. Sobin, L. H., and Fleming, I. D. TNM Classification of Malignant Tumours, Ed. 5. Union Internationale Contre le Cancer and the American Joint Committee on Cancer. Cancer (Phila.), 80: 1803-1804, 1997.
28. Dalbagni, G., Presti, J., Reuter, V., Fair, W. R., and Cordon-Cardo, C. Genetic alterations in bladder cancer. Lancet, 342: 469-471, 1993.
29. Fadl-Elmula, I., Gorunova, I., Mandahl, N., Elfving, P., Lundgren, R., Mitelman, F., and Heim, S. Cytogenetic monoclonality in multifocal uroepithelial carcinomas: evidence of intraluminal tumour seeding. Br. J. Cancer, 81: 6-12, 1999.
30. Louhelainen, J., Wijkstrom, H., and Hemminki, K. Allelic losses demonstrate monoclonality of multifocal bladder tumors. Int. J. Cancer, 87: 522-527, 2000.
31. van Tilborg, A. A., de Vries, A., de Bont, M., Groenfeld, L. E., van der Kwast, T. H., and Zwarthoff, E. C. Molecular evolution of multiple recurrent cancers of the bladder. Hum. Mol. Genet., 9: 2973-2980, 2000.
32. Xu, X., Stower, M. J., Reid, I. N., Garner, R. C., and Burns, P. A. Molecular screening of multifocal transitional cell carcinoma of the bladder using p53 mutations as biomarkers. Clin. Cancer Res., 2: 1795-1800, 1996.
33. Prescott, J. L., Montie, J., Pugh, T. W., McHugh, T., and Veltri, R. W. Clinical sensitivity of p53 mutation detection in matched bladder tumor, bladder wash, and voided urine specimens. Cancer (Phila.), 91: 2127-2135, 2001.
34. Kwok, P. Y. Methods for genotyping single nucleotide polymorphisms. Annu. Rev. Genomics Hum. Genet., 2: 235-258, 2001.
35. Christensen, M., Wolf, H., and Orntoft, T. F. Microsatellite alterations in urinary sediments from patients with cystitis and bladder cancer. Int. J. Cancer, 85: 614-617, 2000.